Pharmaceutical Working Group Position Paper 2022/2023 - 制药工作组建议书2022/2023 Go back »

Download

• English Version (PDF)
• 中文版 (PDF)

The Pharmaceutical Working Group represents nearly 40 international pharmaceutical manufacturing companies operating in China. The working group engages in a constructive dialogue with Chinese central and local authorities to support the development of a sustainable pharmaceutical ecosystem, and government policies that foster innovation and patients’ access to affordable, innovative and highquality healthcare solutions. In particular, the working group has established a sound communication channel with the Chinese healthcare and regulatory authorities, with whom it shares its expertise and policy recommendations based on international best practices and members’ experiences accumulated during decades of healthcare reform in European countries.